Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PCR techniques for clonality assays.

S J Diaz-Cano1, A Blanes, H J Wolfe

  • 1Department of Pathology, Tufts University-New England Medical Center, Boston, Massachusetts, USA. s.j.diaz-cano@mds.qmw.ac.uk

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|March 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paratumoral gene expression profiles: promising markers of malignancy in melanocytic lesions.

The British journal of dermatology·2011
Same author

General morphological and biological features of neoplasms: integration of molecular findings.

Histopathology·2008
Same author

Trichilemmal carcinoma with neuroendocrine differentiation.

Clinical and experimental dermatology·2007
Same author

The correlation of regression with the grade of dysplasia (atypia) in melanocytic naevi.

Histopathology·2007
Same author

Differential kinetic features by tumour topography in cutaneous small-cell neuroendocrine (Merkel cell) carcinomas.

Journal of the European Academy of Dermatology and Venereology : JEADV·2007
Same author

Microsatellite abnormalities and somatic down-regulation of mismatch repair characterize nodular-trabecular muscle-invasive urothelial carcinoma of the bladder.

Histopathology·2007
Same journal

Diagnostic molecular pathology: AIMMing higher.

Diagnostic molecular pathology : the American journal of surgical pathology, part B·2013
Same journal

A comparison of methods for EGFR mutation testing in non-small cell lung cancer.

Diagnostic molecular pathology : the American journal of surgical pathology, part B·2013
Same journal

EGFR autophosphorylation but not protein score correlates with histologic and molecular subtypes in lung adenocarcinoma.

Diagnostic molecular pathology : the American journal of surgical pathology, part B·2013
Same journal

Influence of parasite density and sample storage time on the reliability of Entamoeba histolytica-specific PCR from formalin-fixed and paraffin-embedded tissues.

Diagnostic molecular pathology : the American journal of surgical pathology, part B·2013
Same journal

A comparative study of standard cytogenetic evaluation and molecular karyotyping for products of conception.

Diagnostic molecular pathology : the American journal of surgical pathology, part B·2013
Same journal

Development and clinical validation of a multiplex real-time PCR assay for herpes simplex and varicella zoster virus.

Diagnostic molecular pathology : the American journal of surgical pathology, part B·2013
See all related articles

Loss of heterozygosity (LOH) analysis detects clonal expansions in neoplasms, aiding in diagnosing lymphomas and understanding tumor evolution. X-linked markers offer complementary clonality information in female subjects.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Clonal overgrowths are characteristic of neoplastic proliferations.
  • Detecting gene rearrangements is crucial for diagnosing malignant lymphomas.
  • Nonrandom genetic alterations help assess clonal expansions and evolution in neoplasms.

Purpose of the Study:

  • To explore the utility of genetic alterations, specifically loss of heterozygosity (LOH), in analyzing clonal expansions and tumor evolution.
  • To investigate the application of both non-X-linked and X-linked markers for clonality assessment.
  • To highlight the clinical applications of these molecular tools in oncology.

Main Methods:

  • Analysis of hypervariable deoxyribonucleic acid (DNA) regions in heterozygous patients.

Related Experiment Videos

  • Demonstration of loss of heterozygosity (LOH) through hemizygosity or homozygosity of mutant alleles.
  • Utilizing X-linked markers and methylation-sensitive restriction endonucleases for clonality in female subjects.

    • Main Results:

    • LOH analyses effectively identify clonal expansions and monoclonal proliferation in tumor cell populations.
    • X-linked marker analyses provide complementary clonality information, independent of malignant transformation pathways.
    • These methods can establish tumor heterogeneity, detect early relapses, and differentiate tumor growth patterns.

    Conclusions:

    • Loss of heterozygosity (LOH) analysis is a powerful tool for assessing clonality and tumor evolution.
    • Complementary information from non-X-linked and X-linked markers enhances diagnostic capabilities.
    • These molecular techniques have significant clinical applications in distinguishing tumor types and monitoring disease progression.